| Title |
Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
|
|---|---|
| Published in |
ClinicoEconomics and Outcomes Research: CEOR, July 2013
|
| DOI | 10.2147/ceor.s42755 |
| Pubmed ID | |
| Authors |
Josep Darbà, Nuria Pérez-Álvarez, Lisette Kaskens, Susana Holgado-Pérez, Jill Racketa, Javier Rejas |
| Abstract |
The purpose of this study was to assess the cost-effectiveness of bazedoxifene and raloxifene for prevention of vertebral and nonvertebral fractures among postmenopausal Spanish women aged 55-82 years with established osteoporosis and a high fracture risk. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 3% |
| Spain | 1 | 3% |
| India | 1 | 3% |
| Unknown | 32 | 91% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 9 | 26% |
| Student > Bachelor | 6 | 17% |
| Student > Master | 4 | 11% |
| Researcher | 4 | 11% |
| Other | 2 | 6% |
| Other | 5 | 14% |
| Unknown | 5 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 40% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
| Economics, Econometrics and Finance | 3 | 9% |
| Mathematics | 2 | 6% |
| Agricultural and Biological Sciences | 2 | 6% |
| Other | 3 | 9% |
| Unknown | 8 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 August 2013.
All research outputs
#16,292,673
of 25,728,855 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#303
of 527 outputs
Outputs of similar age
#121,072
of 207,553 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#10
of 18 outputs
Altmetric has tracked 25,728,855 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 527 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,553 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.